Veterinary Vaccines Market Research Report by Disease (Aquaculture, Companion Animals, and Livestock), Technology, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Veterinary Vaccines Market Research Report by Disease (Aquaculture, Companion Animals, and Livestock), Technology, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
231 Pages
January 2023
Region: Global
360iResearch™
ID: 4829828

UP TO €856EUR$895USD£752GBP OFF until Mar 31^st 2023

The Global Veterinary Vaccines Market size was estimated at USD 9,015.90 million in 2022, USD 9,608.28 million in 2023, and is projected to grow at a CAGR of 6.70% to reach USD 15,154.94 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Veterinary Vaccines Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Veterinary Vaccines Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Veterinary Vaccines Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Veterinary Vaccines Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Veterinary Vaccines Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Disease, the market is studied across Aquaculture, Companion Animals, Livestock, Porcine, and Poultry. The Companion Animals is further studied across Canine, Equine, and Feline. The Livestock is further studied across Bovine and Small Ruminants.
Based on Technology, the market is studied across Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, and Toxoid Vaccines.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Veterinary Vaccines Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Veterinary Vaccines Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Veterinary Vaccines Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Veterinary Vaccines Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Veterinary Vaccines Market, including Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health, Heska Corporation, Hester Biosciences Limited, HIPRA, S.A., IDT Biologika GmbH, Indian Immunologicals Ltd., Merck & Co., Inc., Phibro Animal Health Corporation, Torigen Pharmaceuticals Inc., Virbac SA, and Zoetis Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Veterinary Vaccines Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Veterinary Vaccines Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Veterinary Vaccines Market?
4. What is the competitive strategic window for opportunities in the Global Veterinary Vaccines Market?
5. What are the technology trends and regulatory frameworks in the Global Veterinary Vaccines Market?
6. What is the market share of the leading vendors in the Global Veterinary Vaccines Market?
7. What modes and strategic moves are considered suitable for entering the Global Veterinary Vaccines Market?

Frequently Asked Questions about the Global Veterinary Vaccines Market

What is the estimated value of the Global Veterinary Vaccines Market?

The Global Veterinary Vaccines Market was estimated to be valued at $9015.9 Million in 2022.

What is the growth rate of the Global Veterinary Vaccines Market?

The growth rate of the Global Veterinary Vaccines Market is 6.7%, with an estimated value of $15154.94 Million by 2030.

What is the forecasted size of the Global Veterinary Vaccines Market?

The Global Veterinary Vaccines Market is estimated to be worth $15154.94 Million by 2030.

Who are the key companies in the Global Veterinary Vaccines Market?

Key companies in the Global Veterinary Vaccines Market include Aptimmune Biologics, Inc., Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Brilliant Bio Pharma Private Limited, Ceva Santé Animale, China Animal Husbandry Industry Co., Ltd, Elanco AB, Endovac Animal Health and Hester Biosciences Limited.

Report Attribute	Details
No. of Pages	231
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 9015.9 Million
Forecasted Market Value ( USD ) by 2030	$ 15154.94 Million
Compound Annual Growth Rate	6.7%
Regions Covered	Global
No. of Companies Mentioned	18

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing number of companion animal and livestock ownership
5.1.1.2. Improving veterinary care facilities in economies
5.1.1.3. Rising incidence of chronic diseases and accidental injuries in animals
5.1.2. Restraints
5.1.2.1. High storage costs for vaccines
5.1.3. Opportunities
5.1.3.1. Rising investments in veterinary vaccine R&D
5.1.3.2. Growing availability of pet insurance
5.1.4. Challenges
5.1.4.1. Inadequate surveillance and reporting systems
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Veterinary Vaccines Market, by Disease
6.1. Introduction
6.2. Aquaculture
6.3. Companion Animals
6.4.1. Canine
6.4.2. Equine
6.4.3. Feline
6.4. Livestock
6.5.1. Bovine
6.5.2. Small Ruminants
6.5. Porcine
6.6. Poultry

7. Veterinary Vaccines Market, by Technology
7.1. Introduction
7.2. Inactivated Vaccines
7.3. Live Attenuated Vaccines
7.4. Recombinant Vaccines
7.5. Toxoid Vaccines

8. Americas Veterinary Vaccines Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Veterinary Vaccines Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Veterinary Vaccines Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Aptimmune Biologics, Inc.
12.2. Biogenesis Bago SA
12.3. Boehringer Ingelheim International GmbH
12.4. Brilliant Bio Pharma Private Limited
12.5. Ceva Santé Animale
12.6. China Animal Husbandry Industry Co., Ltd
12.7. Elanco AB
12.8. Endovac Animal Health
12.9. Heska Corporation
12.10. Hester Biosciences Limited
12.11. HIPRA, S.A.
12.12. IDT Biologika GmbH
12.13. Indian Immunologicals Ltd.
12.14. Merck & Co., Inc.
12.15. Phibro Animal Health Corporation
12.16. Torigen Pharmaceuticals Inc.
12.17. Virbac SA
12.18. Zoetis Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL VETERINARY VACCINES MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL VETERINARY VACCINES MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL VETERINARY VACCINES MARKET DYNAMICS
FIGURE 11. GLOBAL VETERINARY VACCINES MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2030 (%)
FIGURE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY DISEASE, 2030
FIGURE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
FIGURE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
FIGURE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
FIGURE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, 2018-2030 (USD MILLION)
FIGURE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
FIGURE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. GLOBAL VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 28. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, 2018-2030 (USD MILLION)
FIGURE 29. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2030 (USD MILLION)
FIGURE 30. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
FIGURE 31. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, 2018-2030 (USD MILLION)
FIGURE 32. AMERICAS VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 34. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. AMERICAS VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 36. ARGENTINA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. BRAZIL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. CANADA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. MEXICO VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 42. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 43. UNITED STATES VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 44. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 46. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 47. ASIA-PACIFIC VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 48. AUSTRALIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. CHINA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. INDIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. INDONESIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. JAPAN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. MALAYSIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. PHILIPPINES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. SINGAPORE VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 56. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. TAIWAN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. THAILAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. VIETNAM VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 63. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 64. DENMARK VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. EGYPT VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. FINLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. FRANCE VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. GERMANY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. ISRAEL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. ITALY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. NETHERLANDS VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. NIGERIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. NORWAY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. POLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. QATAR VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. RUSSIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 78. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 79. SPAIN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 80. SWEDEN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 81. SWITZERLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 82. TURKEY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 83. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 84. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 85. GLOBAL VETERINARY VACCINES MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 86. GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 87. GLOBAL VETERINARY VACCINES MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL VETERINARY VACCINES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VETERINARY VACCINES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL VETERINARY VACCINES MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL VETERINARY VACCINES MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL VETERINARY VACCINES MARKET SIZE, BY CANINE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL VETERINARY VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL VETERINARY VACCINES MARKET SIZE, BY CANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL VETERINARY VACCINES MARKET SIZE, BY EQUINE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL VETERINARY VACCINES MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL VETERINARY VACCINES MARKET SIZE, BY EQUINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL VETERINARY VACCINES MARKET SIZE, BY FELINE, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL VETERINARY VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL VETERINARY VACCINES MARKET SIZE, BY FELINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL VETERINARY VACCINES MARKET SIZE, BY BOVINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL VETERINARY VACCINES MARKET SIZE, BY SMALL RUMINANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL VETERINARY VACCINES MARKET SIZE, BY PORCINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL VETERINARY VACCINES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL VETERINARY VACCINES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL VETERINARY VACCINES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL VETERINARY VACCINES MARKET SIZE, BY RECOMBINANT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL VETERINARY VACCINES MARKET SIZE, BY TOXOID VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. CANADA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 61. CANADA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. CANADA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 63. MEXICO VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 65. MEXICO VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 72. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. AUSTRALIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 76. AUSTRALIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. CHINA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. CHINA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 79. CHINA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. INDIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 81. INDIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 82. INDIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. JAPAN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 88. JAPAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. MALAYSIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 94. PHILIPPINES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 97. SINGAPORE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 99. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 100. SOUTH KOREA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. TAIWAN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 102. TAIWAN VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 103. TAIWAN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. THAILAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 105. THAILAND VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. THAILAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. VIETNAM VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 108. VIETNAM VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 109. VIETNAM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. DENMARK VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 115. DENMARK VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 116. DENMARK VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. EGYPT VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. EGYPT VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 119. EGYPT VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 120. FINLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. FINLAND VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 122. FINLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. FRANCE VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 125. FRANCE VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 126. GERMANY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. GERMANY VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 132. ITALY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. ITALY VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 134. ITALY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 140. NIGERIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. NORWAY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 142. NORWAY VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 143. NORWAY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 144. POLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 145. POLAND VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 146. POLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. QATAR VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. QATAR VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 149. QATAR VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 156. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 157. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 159. SPAIN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 160. SPAIN VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 163. SWEDEN VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 164. SWEDEN VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 168. TURKEY VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 169. TURKEY VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 170. TURKEY VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 173. UNITED ARAB EMIRATES VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 174. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 176. UNITED KINGDOM VETERINARY VACCINES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. GLOBAL VETERINARY VACCINES MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 178. GLOBAL VETERINARY VACCINES MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 179. GLOBAL VETERINARY VACCINES MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 180. GLOBAL VETERINARY VACCINES MARKET RANKING, BY KEY PLAYER, 2022
TABLE 181. GLOBAL VETERINARY VACCINES MARKET SHARE, BY KEY PLAYER, 2022
TABLE 182. GLOBAL VETERINARY VACCINES MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 183. GLOBAL VETERINARY VACCINES MARKET MERGER & ACQUISITION
TABLE 184. GLOBAL VETERINARY VACCINES MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 185. GLOBAL VETERINARY VACCINES MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 186. GLOBAL VETERINARY VACCINES MARKET INVESTMENT & FUNDING
TABLE 187. GLOBAL VETERINARY VACCINES MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 188. GLOBAL VETERINARY VACCINES MARKET: LICENSE & PRICING